Healthline
October 23, 2025
Share on PinterestExperts say California’s new affordable insulin program is a breakthrough for people with diabetes. Getty Images California has launched a program to manufacture and […]
October 22, 2025
Share on PinterestMany popular protein powders and shakes may contain lead, according to Consumer Reports. Anna Blazhuk/Getty Images A new Consumer Reports investigation found that many […]
October 21, 2025
Share on PinterestA new drug combo therapy significantly improved overall survival rates in males with locally advanced prostate cancer. Maskot/Getty Images A drug combination already used […]
October 18, 2025
Share on PinterestNew recommendations for constipation identify specific foods, supplements, and drinks that can improve symptoms. Zoa Photo/Stocksy United The British Dietetic Association has released dietary […]
Medscape
July 4, 2025
TOPLINE: Patients with autoimmune skin diseases (ASDs) showed significantly lower risks for death after cancer treatment than those without ASDs, especially those with alopecia areata or […]
July 4, 2025
Digital twins are rapidly emerging as powerful tools in personalized medicine and beyond. In healthcare, they serve as virtual representations of a patient’s body, body parts, […]
July 3, 2025
The prevalence of irritable bowel syndrome (IBS) and chronic idiopathic constipation among US adults rose significantly during the COVID-19 pandemic, with a near doubling of the […]
July 3, 2025
TOPLINE: Patients with Crohn’s disease who undergo terminal ileum resection have a significantly higher risk of developing colorectal cancer (CRC) and colorectal polyps than those who […]
FDA
November 18, 2025
Complex generic products are typically harder to develop, which means that many complex products face less competition than other products, and therefore can be more expensive […]
November 18, 2025
Search NDC What are the NDC Number and the National Drug Code Directory? Section 510 of the Federal Food, Drug and Cosmetic Act (Act), 21 U.S.C. […]
November 18, 2025
Action Today, the U.S. Food and Drug Administration (FDA) approved Redemplo (plozasiran) as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome […]
November 18, 2025
On November 18, 2025, the Food and Drug Administration approved epcoritamab-bysp (Epkinly, Genmab US, Inc.) with lenalidomide and rituximab for relapsed or refractory follicular lymphoma (FL). […]
